The STARBOARD trial will investigate encorafenib, binimetinib and pembrolizumab as a combination therapy for BRAF V600 mutant melanoma. In this touchONCOLOGY interview, we speak with Dr Ryan Sullivan (Mass General Cancer Center, Boston, MA, USA) to discuss the mechanisms of encorafenib, binimetinib and pembrolizumab, as well as details on the STARBOARD trial. The presentation entitled […]

Multiple therapies that have been approved for the treatment of BRAF V600 mutated melanoma. In this touchONCOLOGY interview, we speak with Dr Ryan Sullivan (Mass General Cancer Center, Boston, MA, USA) to discuss the current treatment paradigm and its limitations. Ryan Sullivan presented an abstract entitled ‘Randomized phase 3 study (STARBOARD) evaluating encorafenib (enco) + […]

President of the European Society for Paediatric Oncology (SIOPE Europe), Prof Carmelo Rizzari, discusses his highlights from the SIOPE Europe 2023 annual meeting. This year it was attended by 1200 individuals, bringing together healthcare professionals, parents, patients, caregivers, young oncologists, nurses and many other groups involved in the paediatric oncology.  There were 150 sessions and […]

President of the European Society for Paediatric Oncology (SIOPE Europe), Prof Carmelo Rizzari, provides an interesting update on the society, the recent annual meeting, the mission and future objectives. Topics covered  SIOPE structure (01:11) Membership, Board and SIOPE Office (05:00) Initiatives and Mission (08:00) Education, AI, GDPR (09:30)  Support for survivors (12:10) SIOPE Meeting 2023 […]

Secretary General of the European Association of Urology (EAU), Prof Arnulf Stenzl, discusses what he hopes to see in the field of uro-oncological surgery in the next five years. He hopes this will include improving early detection of prostate cancer and therefore the possibility of avoiding surgery; improving prognostic factors and diagnosis in early disease […]

It was a pleasure to hear from the Secretary General of the European Association of Urology (EAU), Prof Arnulf Stenzl, to discuss some of the pivotal new projects and initiatives the society are currently working on. Topics covered Minimalise any uro-oncologic surgery, more precise, complete removal of tumour, improving outcomes (00:37) Developments in robot-assisted surgery […]

It was a pleasure to hear from the Secretary General of the European Association of Urology (EAU), Prof Arnulf Stenzl, to discuss some of the pivotal new projects and initiatives the society are currently working on. Topics covered Meetings and introducing more virtual, web-based education post-COVID (00:20) Projects, real-world data, future strategies (3:30) Development of […]

touchONCOLOGY caught up with the Secretary General of the European Association of Urology (EAU), Prof Arnulf Stenzl, to discuss some of the key advances from the conference. He focusses this interview on prostate cancer, early detection, systemic therapy, new therapies in castration-resistant prostate cancer and the latest knowledge in the use of PARP inhibitors. Topics […]

Intraoperative molecular imaging enables surgeons to utilise a cancer specific fluorescent dye to improve cancer removal. In this touchONCOLOGY interview, we speak with Dr Sunil Singhal (University of Pennsylvania, Philadelphia, PA, USA) to discuss intraoperative molecular imaging, with focus on its application in lung cancer. The presentation entitled ‘Intraoperative molecular imaging of lung cancer: The […]